Treace Medical Concepts (TMCI) Other Working Capital Changes (2020 - 2026)
Treace Medical Concepts (TMCI) posted Other Working Capital Changes of -$235000.0 for Q1 2026, up 71.52% on a QoQ basis from -$825000.0 in Q4 2025, and down 312.28% year-over-year from $110702.5 in Q1 2025.
Treace Medical Concepts (TMCI) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Treace Medical Concepts' Other Working Capital Changes history runs 5 years deep, the most recent figure standing at -$235000.0 for Q1 2026.
- Quarterly Other Working Capital Changes fell 312.28% year-over-year to -$235000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.4 million (down 80.73% YoY) and the FY2025 annual result came in at -$3.2 million, down 29.68% from the prior year.
- Other Working Capital Changes was -$235000.0 for Q1 2026 at Treace Medical Concepts, up from -$825000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $2.3 million in Q2 2022 and bottomed at -$1.7 million in Q2 2024.
- A 5-year average of -$63647.1 and a median of -$390000.0 in 2022 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes soared 4176.92% — and 2025, when it sank 4045.0%.
- Treace Medical Concepts' Other Working Capital Changes stood at $133000.0 in 2022, then slumped by 101.5% to -$2000.0 in 2023, then tumbled by 116200.0% to -$2.3 million in 2024, then soared by 64.53% to -$825000.0 in 2025, then soared by 71.52% to -$235000.0 in 2026.
- Business Quant data shows TMCI's Other Working Capital Changes at -$235000.0 in Q1 2026, -$825000.0 in Q4 2025, and -$829000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Treace Medical Concepts | 261.60 Mn | 209.75 Mn | 37.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -608,000.00 |
| Mar 31, 2026 | -608,000.00 |
| Mar 31, 2026 | -608,000.00 |
| Dec 31, 2025 | -697,000.00 |
| Dec 31, 2025 | -697,000.00 |
| Dec 31, 2025 | -697,000.00 |
| Sep 30, 2025 | 615,000.00 |
| Sep 30, 2025 | 615,000.00 |
| Sep 30, 2025 | 615,000.00 |
| Jun 30, 2025 | 1.29 Mn |
| Jun 30, 2025 | 1.29 Mn |
| Jun 30, 2025 | 1.29 Mn |
| Mar 31, 2025 | -1.37 Mn |
| Mar 31, 2025 | -1.37 Mn |
| Mar 31, 2025 | -1.37 Mn |
| Dec 31, 2024 | -1.35 Mn |
| Dec 31, 2024 | -1.35 Mn |
| Dec 31, 2024 | -1.35 Mn |
| Sep 30, 2024 | -653,000.00 |
| Sep 30, 2024 | -653,000.00 |